HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

α-Synuclein antibody 5G4 identifies manifest and prodromal Parkinson's disease in colonic mucosa.

AuthorsMatej Skorvanek, Ellen Gelpi, Eva Mechirova, Zuzana Ladomirjakova, Vladimir Han, Norbert Lesko, Eva Feketeova, Barbora Repkova, Zuzana Urbancikova, Adriana Vargova, Peter Spisak, Joaquim Ribeiro Ventosa, Filip Kudela, Kristina Kulcsarova, Simona Babinska, Stefan Toth, Laura Gombosova, Maria Zakuciova, Eduard Veseliny, Frantisek Trebuna, Mirjam I Lutz, Zuzana Gdovinova, Gabor G Kovacs, PARCAS studygroup
JournalMovement disorders : official journal of the Movement Disorder Society (Mov Disord) Vol. 33 Issue 8 Pg. 1366-1368 (08 2018) ISSN: 1531-8257 [Electronic] United States
PMID30230627 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies
  • alpha-Synuclein
Topics
  • Aged
  • Antibodies (metabolism)
  • Cohort Studies
  • Colon (pathology)
  • Female
  • Humans
  • Intestinal Mucosa (metabolism)
  • Male
  • Middle Aged
  • Parkinson Disease (pathology)
  • Prodromal Symptoms
  • alpha-Synuclein (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: